-
公开(公告)号：KR1020130044707A
公开(公告)日：2013-05-03
申请号：KR1020110108904
申请日：2011-10-24
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A composition containing syringaresinol is provided to suppress fatty acid synthesis, to promote fatty acid oxidation, to enhance PGC 1 expression, and to prevent and treat obesity and hyperlipidemia. CONSTITUTION: A composition for preventing or treating dysbolism contains 1-80 wt% of syringaresinol as an active ingredient. Dysbolism includes disorders of carbohydrate metabolism or lipid metabolism, selected from the group consisting of obesity, type 2 diabetes, hyperlipidemia, and fatty liver. Syringaresinol is contained in extracts which is prepared using one or more selected among linseed, Phellodendron amurense Ruprecht, Acanthopanax senticosus, sesame seeds, and ginseng fruits. [Reference numerals] (AA) mRNA expression of relative SIRT 1; (BB) Fat cell; (CC) Liver cell; (DD) Muscle cell
Abstract translation: 目的：提供含有丁香胺的组合物，以抑制脂肪酸合成，促进脂肪酸氧化，增强PGC 1表达，并预防和治疗肥胖和高脂血症。 构成：用于预防或治疗dysbolism的组合物含有1-80重量％的作为活性成分的丁香胺。 嗜睡症包括选自肥胖症，2型糖尿病，高脂血症和脂肪肝的碳水化合物代谢或脂质代谢紊乱。 提取物中含有辛伐他汀，该提取物使用亚麻籽，黄柏，麻黄，芝麻，人参果实中的一种或多种进行制备。 （AA）相对于SIRT1的mRNA表达; （BB）脂肪细胞; （CC）肝细胞; （DD）肌肉细胞
-
112.发明公开필발 추출물, 이소플라본을 함유하는 대두 추출물 및 Ｌ-카르니틴을 함유하는 비만 또는 고지혈증 예방용 또는 개선용 조성물 有权用于预防或治疗肥胖或含有大剂量肝素提取物，异丙肾上腺素和左旋肉碱的组合物
公开(公告)号：KR1020120037145A
公开(公告)日：2012-04-19
申请号：KR1020100098725
申请日：2010-10-11
Applicant: (주)아모레퍼시픽
IPC: A61K36/67 , A61K31/352 , A61K31/35
Abstract: PURPOSE: A composition containisng Piper longum L. extract, isoflavone, and L-carnitine is provided to reduce body fat and body weight and to enhance energy consumption. CONSTITUTION: A composition for preventing or treating obesity contains 0.0001-10 wt% of Piper longum L. extract, 0.0001-10 wt% of isoflavone, and 0.001-40 wt% of L-carnitine as an active ingredient. The composition is used for suppressing neutral fat. A composition for treating or preventing hyperlipidemia contains the Piper longum L. extract, isoflavone, and L-carnitine as an active ingredient.
Abstract translation: 目的：提供琵琶龙提取物，异黄酮和L-肉碱的组合物，以减少体脂肪和体重，增加能量消耗。 构成：用于预防或治疗肥胖症的组合物含有0.0001-10重量％的琵琶龙提取物，0.0001-10重量％的异黄酮和0.001-40重量％的左旋肉碱作为活性成分。 该组合物用于抑制中性脂肪。 用于治疗或预防高脂血症的组合物含有琵琶长叶提取物，异黄酮和L-肉毒碱作为活性成分。
-
公开(公告)号：KR1020110082866A
公开(公告)日：2011-07-20
申请号：KR1020100002777
申请日：2010-01-12
Applicant: (주)아모레퍼시픽
Abstract: PURPOSE: A producing method of a red ginseng extract using a charcoal filtration system, and the red ginseng extract are provided to secure the excellent palatability of the red ginseng extract. CONSTITUTION: A producing method of a red ginseng extract comprises the following steps: passing water through a charcoal filtration system for obtaining charcoal filtration purified water; sterilizing the charcoal filtration purified water; and extracting active components of red ginseng using the charcoal filtration purified water. The charcoal filtration system includes charcoal selected from quercus acutissima charcoal, pinus densiflora charcoal, or bamboo charcoal. The extracting process is performed at 80~100deg C, and is repeated for 3~4times.
Abstract translation: 目的：提供红参提取物的红参提取物，红参提取物的红参提取物的制备方法，红参提取物的优良适口性。 构成：红参提取物的制备方法包括以下步骤：将水通过木炭过滤系统获得木炭过滤净化水; 对木炭过滤净化水进行灭菌; 并使用炭过滤净化水提取红参的活性成分。 木炭过滤系统包括从栎木炭，松木炭或竹炭中选择的木炭。 提取过程在80〜100℃下进行，重复3〜4次。
-
公开(公告)号：KR1020110060002A
公开(公告)日：2011-06-08
申请号：KR1020090116467
申请日：2009-11-30
Applicant: (주)아모레퍼시픽
IPC: A61K36/82 , A61K31/715 , A61P1/16 , A61P25/32
Abstract: PURPOSE: A composition containing post-fermented tea extract an chitooligosaccharide is provided to reduce hangover and blood acetate concentration. CONSTITUTION: A composition for relieving hangover contains post-fermented tea extract and chitooligosaccharide in a weight ratio of 1:1-1:5. The post-fermented tea extract is obtained using non-pathogenic microorganism such as Saccharomyces sp., Bacillus sp., or Aspergillus sp. A liver protective agent or fatigue recovery agent contains the composition.
Abstract translation: 目的：提供含有发酵后茶提取物的壳寡糖的组合物，以减少宿醉和血液乙酸盐浓度。 构成：用于缓解宿醉的组合物含有重量比为1：1-1：5的后发酵茶提取物和壳低聚糖。 后发酵茶提取物是使用非致病微生物如酵母属，芽孢杆菌属或曲霉属种获得的。 肝保护剂或疲劳恢复剂含有该组合物。
-
115.发明公开리그난 유도체를 함유하는 세라마이드 대사관련 효소에 의해 매개되는 질환의 예방 또는 치료용 조성물 有权用于预防或治疗包含作为活性成分的Larianan衍生物的CERAMIDE代谢相关酶介导的疾病的组合物
公开(公告)号：KR1020100059050A
公开(公告)日：2010-06-04
申请号：KR1020080117688
申请日：2008-11-25
Applicant: (주)아모레퍼시픽
IPC: A61K31/192 , A61K31/343 , A61P3/00
CPC classification number: A61K31/192 , A61K31/343
Abstract: PURPOSE: A composition containing lignin derivative is provided to treat atopic dermatitis or xerosis to also treat diseases mediated by ceramide metabolic enzyme. CONSTITUTION: A composition for preventing or treating diseases mediated by ceramide metabolic enzyme contains rosmarinic acid of chemical formula 1, lithospermic acid of chemical formula 2, 9"-methyl lithospermate of chemical formula 2, or lignin derivative of 9'-methyl lithospermate of chemical formula 2 as an active ingredient. The composition enhances ceramide content on the epidermis.
Abstract translation: 目的：提供含有木质素衍生物的组合物治疗特应性皮炎或干性病，还可治疗由神经酰胺代谢酶介导的疾病。 构成：用于预防或治疗由神经酰胺代谢酶介导的疾病的组合物含有化学式1的迷迭香酸，化学式2的化学式2，化学式2的9“ - 甲基紫精的化学式，或化学式为9'-甲基紫苏的木质素衍生物 配方2作为活性成分。组合物增强表皮上的神经酰胺含量。
-
Patent Agency Ranking
公开(公告)号：KR1020100032603A
公开(公告)日：2010-03-26
申请号：KR1020080091563
申请日：2008-09-18
Applicant: (주)아모레퍼시픽
IPC: G01N21/25 , G01N21/359 , G01N33/02
Abstract: PURPOSE: A method for verifying prediction about a yield and quality of a fresh red ginseng and red ginseng juice using a near-infrared-spectrum system is provided to verify a yield and quality in a short time through a correlation calibration curve. CONSTITUTION: A method for verifying prediction about a yield and quality of a fresh red ginseng and red ginseng juice using a near-infrared-spectrum system is as follows. Multiple fresh ginsengs are respectively measured using a near-infrared spectrum. The fresh ginsengs are processed to red ginsengs. Yields of the red ginsengs, red ginseng juice, ginsenoside contents, and moisture contents of the fresh ginsengs are measured. A correlation of a normal value and a spectrum is displayed as a calibration curve.
Abstract translation: 目的：提供一种使用近红外光谱系统验证新鲜红参和红参果汁的产量和质量的预测方法，通过相关校准曲线在短时间内验证产量和质量。 构成：使用近红外光谱系统验证新鲜红参和红参果汁的产量和质量的预测方法如下。 使用近红外光谱分别测量多个新鲜人参。 新鲜人参被加工成红参。 测定红参中红参，红参，人参皂甙含量，水分含量。 正常值和光谱的相关性显示为校准曲线。
-
公开(公告)号：KR100902223B1
公开(公告)日：2009-06-11
申请号：KR1020070074108
申请日：2007-07-24
IPC: A61K9/48
Abstract: 본 발명은 관절 및 연골의 구성성분으로 관절 및 연골의 건강에 도움을 주는 성분을 높은 밀도로 함유하는 연질 캡슐에 대한 것으로서, 캡슐의 안정성과 복용 후 붕해 속도를 개선하여 생체이용률을 향상시킨 연질 캡슐 제제에 관한 것이다. 더욱 구체적으로 본 발명은 글루코사민 또는 약제학적으로 허용되는 그 염을 한 유효 성분으로 하는 구성에 상어 연골 추출 분말, 생강 버드나무 추출 분말, 홉 추출물, 녹색입(green-lipped) 홍합 분말 중의 어느 하나 이상의 비글루코사민 유효 성분을 선택적으로 포함할 수 있는 연질 캡슐에 대한 것이다. 본 발명의 연질 캡슐은 붕해 안정성을 조절하기 위하여 호박산 젤라틴 및 중간 사슬 트리글리세리드유(MCT oil)를 사용하고, 인체에 안전한 천연 색소를 사용하였기 때문에 관절염 환자의 증상 완화와 관절 보호에 효과가 있을 것으로 예상된다.
글루코사민, 호박산 젤라틴, MCT, 연질 캡슐, 천연색소-
公开(公告)号：KR1020080049330A
公开(公告)日：2008-06-04
申请号：KR1020060119769
申请日：2006-11-30
Applicant: (주)아모레퍼시픽
CPC classification number: A23L33/19 , A23L29/244 , A23L33/105 , A23L33/185 , A23L33/40
Abstract: A food composition including glucomannan, whey protein and isolated soybean protein as essential nutrients is provided to maximize a feeling of satiety during or after a meal, and thus can be effective to induce weight loss. A food composition contains 0.1 to 33% by weight of whey protein, 0.1 to 30% by weight of isolated soybean protein, 0.01 to 10% by weight of glucomannan and additionally vitamin or inorganic matter and 1 to 50% by weight of Chia seed. The weight ratio of glucomannan, whey protein and isolated soybean protein is 0.25 to 1.25:1.0 to 4.55:1.37 to 7.94. The food composition is formulated into dry powder, granule, capsule, tablet, pill, drink, oil-phase liquid, diet bar, chocolate, caramel, cereal and confectionery and has a caloric content of 50 to 500Kcal.
Abstract translation: 提供包括葡甘露聚糖，乳清蛋白和分离的大豆蛋白作为必需营养素的食物组合物，以在餐中或餐后最大化饱腹感，因此可有效诱导体重减轻。 食品组合物含有0.1〜33重量％的乳清蛋白，0.1〜30重量％的分离的大豆蛋白，0.01〜10重量％的葡甘露聚糖，另外含有维生素或无机物质，1〜50重量％的Chia种子。 葡甘聚糖，乳清蛋白和分离的大豆蛋白的重量比为0.25〜1.25：1.0〜4.55：1.37〜7.94。 食品组合物配制成干粉，颗粒，胶囊，片剂，丸剂，饮料，油相液体，饮食棒，巧克力，焦糖，谷物和糖果，热量含量为50〜500Kcal。
-
公开(公告)号：KR100833705B1
公开(公告)日：2008-05-29
申请号：KR1020020088024
申请日：2002-12-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/185 , A61P9/08
Abstract: 본 발명은 우수한 혈관이완효과를 갖는 Orira(
Anogeissus leiocarpus ), Gboigboi(
Cnestis sp .) 또는 Osusu(
Drypetes molunduana) 추출물을 함유하는 혈액순환제 또는 혈관이완제에 관한 것이다. 보다 상세하게는, 아프리카에서 자생하는 Orira(
Anogeissus leiocarpus ), Gboigboi(
Cnestis sp .) 및 Osusu(
Drypetes molunduana) 의 뿌리를 유기용매로 추출한 추출물 및 상기 추출물을 유기용매로 분획화한 분획물을 함유하는 혈액순환제 또는 혈관이완제에 관한 것이다.
Orira * Gboiboi * Osusu * 혈관 이완 * 혈액 순환 * 5-HT-
公开(公告)号：KR1020040061732A
公开(公告)日：2004-07-07
申请号：KR1020020088024
申请日：2002-12-31
Applicant: (주)아모레퍼시픽
IPC: A61K36/185 , A61P9/08
Abstract: PURPOSE: Provided are extracts of Anogeissus leiocarpus, Cnestis sp. and Drypetes molunduana and fractions thereof which are used as raw materials of blood circulating agents and blood vessel relaxants. CONSTITUTION: Blood circulating agents and blood vessel relaxants are characterized by containing at least one kind of extracts of Anogeissus leiocarpus, Cnestis sp. and Drypetes molunduana and fractions thereof. The extracts are obtained by using methanol as an extraction solvent, filtering the extracts, concentrating the filtrates and drying them. A pharmaceutical composition contains at least one kind of the extracts of Anogeissus leiocarpus, Cnestis sp. and Drypetes molunduana.
Abstract translation: 目的：提供of藜（Anogeissus leiocarpus），Cnestis sp。 和Drypetes molunduana及其级分，用作血液循环剂和血管松弛剂的原料。 构成：血液循环剂和血管松弛剂的特征在于含有至少一种Anogeissus leiocarpus，Cnestis sp。 和Drypetes molunduana及其级分。 通过使用甲醇作为提取溶剂获得提取物，过滤提取物，浓缩滤液并干燥。 一种药物组合物含有至少一种Anogeissus leiocarpus，Cnestis sp。 和Drypetes molunduana。
-
-
-
-
-
-
-
-
-
Search Results
146
records
(took 0.031 seconds)
